|Research your Stock | Technical Calls | Live Market Action | Archives | Join Xchange|
Welcome to Market Insights.
We are drafting this edition at a time when two leading companies in the pharmaceuticals and clinical diagnostics arena, viz. Dr. Lal Pathlabs and Alkem Laboratories, are testing their fate on the IPO route. While investors have always favoured the pharma sector, several leading brokers have responded to the IPO favourably recommending investors to subscribe for both the IPOs. In this edition, our readers will be able to read insights on both these IPOs from several leading brokers like HDFC Sec, Hem Securities, Nirmal Bang, SMC, and SKP Securities among others at a single click.
Apart from this, Aditya Trading Solutions are sharing with our readers their model portfolio for the month of December 2015. Meanwhile, SMC are recommending investors to buy Tata Chemicals and Godrej Industries for the upside potential they hold, justifying their recommendations on fundamental fronts.
Continuing to advise investors, this edition finds Religare Online recommending Dish TV as a Master Equity Pick for December 2015. Carrying forward from the previous edition, we also offer our readers an opportunity to approach experts at Religare Online with their queries related to investments in stocks, commodities, and currencies.
If you like us, please rate us on Facebook.
|Dr. Lal Pathlabs IPO: Insights from all leading brokers|
|After having expanded to a National Reference Laboratory in New Delhi, 163 other clinical laboratories, 1,340 patient service centers and over 5,000 pickup points as of March 31, 2015, Delhi-based Dr. Lal PathLabs Limited is launching an IPO offering for sale up to 11,600,000 Equity Shares, and aiming at the benefits of listing the Equity Shares on the Stock Exchanges. This section provides a wider insight on why most of the leading brokers are recommending to Subscribe for this issue.
|Alkem Laboratories IPO: Insights from all leading brokers|
|Alkem Laboratories is already equipped with a portfolio of over 736 brands in India, a total of 16 manufacturing facilities, four research and development facilities, and a team of 483 scientists in research and development functions. It is now offering for sale 12,853,442 Equity Shares by the Selling Shareholders in order to achieve the benefits of listing the Equity Shares on the Stock Exchanges. This section provides an insight on why most of the leading brokers are in favour of this IPO.
|Aditya Trading Solutions recommend model portfolio for December 2015|
|The model portfolio for December 2015 drafted by Aditya Trading Solutions (ATS Research) includes scrips like Tata Steel, Reliance Infrastructure, Uflex, Larsen & Toubro, and Biocon. Read the elaborate report by ATS Research, which justifies their recommendations and also comments on the overall economy.
|Fundamental picks: These stocks have an upside of 35% & 33% respectively|
|According to SMC, Tata Chemicals is expected to see good growth across its businesses as the Indian market will continue the overall growth momentum. The company particularly believes in the long term fundamentals of the soda ash and sodium bicarbonate industry. Similarly, Godrej Industries continues to be in the growth trajectory despite weak monsoon and demand environment; and management initiatives towards brand building, acquisitions and focus on cost control and operational efficiency would give positive impact for the tremendous growth. Hence, investors can buy both these scrips over the next 8-10 months.
|Featured Technical Call for today by Mr. Bilal Khair
BAJFINANCE (FUTURE), BUY INTRADAY FOR ENTRY LEVELS OF 5460 - 5480 and STOP-LOSS OF 5399
|Ask an Expert - An answer to your question is just an e-mail away!|
|One of our readers and an active investor had approached our experts asking for views on prospects of KEI Industries for the medium term investment and probable targets for it. As always, Rakesh Rathod gave a prompt response while Mr. Rakesh Sethi also offered his insights about the scrip.
IndiaNotes.com's Ask an Expert section has been very popular among our audience and readers, particularly because of our experts on board like Mr. Rakesh Rathod and Mr. Rakesh Sethi among others for the prompt and convincing solutions they offer.
Readers are most welcome to post their questions to our experts on board and get their queries answered.
|Advertise with us | Write for us | Blog on Xchange | Archives | Feedback|